Buy orders are stating to build up and there is very little sell volume to satisfy them which is why volume is still low. Positive results due out this month could easily double the SP.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025